The Marlboro-maker will pay 150 pence per share in cash, valuing Vectura at £1.0 billion ($1.4 billion, 1.2 billion euros), the pair said i...

Vectura's Chairman Bruno Angelici said the company had made strong progress since embarking on a strategy in 2019 to become a leading inhal...

The generic would be used for treatment of asthma and chronic obstructive pulmonary disease.